CREATING BUDGETS - THE BASICS

Size: px
Start display at page:

Download "CREATING BUDGETS - THE BASICS"

Transcription

1 CREATING BUDGETS - THE BASICS

2 AGENDA REVIEW OF STUDY PROTOCOL AND DESIGN REVIEW OF STUDY SCHEMA DEVELOPMENT OF STUDY BUDGET BUDGET NEGOTIATION BUDGET MANAGEMENT REIMBURSEMENT

3 Review of Study Protocol and Design Protocol Review Department Review IRB Review Develop and Negotiate Budget Contract Review and Negotiation Finalize: Budget Contract IRB

4 STUDY SCHEMA STUDY-REQUIRED LABORATORY TESTS STUDY-REQUIRED PROCEDURES STUDY DRUG ADMINISTRATION AND SCHEDULE; RESEARCH PHARMACY STUDY-SPECIFIC ELEMENTS AFFECTING MANPOWER LOCATION WHERE RESEARCH WILL OCCUR REVIEW PROTOCOL FOR ITEMS NOT IN SCHEMA

5 BUDGET DEVELOPMENT and NEGOTIATION

6 WHAT IS A BUDGET? BUDGET : n 1. Total amount of money allocated for a certain purpose. 2. The estimated cost of living, operating, etc. -vt 1. To put on a budget.

7 ANALYZE THE PROTOCOL LABORATORY TESTS PROCEDURES STUDY DRUG PHARMACY NEEDS RESEARCH NURSING DATA MANAGEMENT ADMINISTRATIVE EFFORT PRINCIPAL INVESTIGATOR SUPPLIES DATA STORAGE PROCEDURES MANPOWER LABS STUDY BUDGET STUDY DRUG PHARMACY OTHER COSTS

8 IDENTIFY STUDY COSTS Key Personnel Lab Costs Procedure Costs Pharmacy Costs Indirect Costs Miscellaneous Costs

9 IDENTIFY KEY PERSONNEL COSTS PRINCIPAL INVESTIGATOR (P.I.) STUDY COORDINATOR DATA MANAGER PHARMACIST ADMINISTRATIVE CLERICAL FINANCIAL NURSE MANAGER REGULATORY

10 PRINCIPAL INVESTIGATOR EVALUATE EFFORT INVOLVEMENT PER PATIENT PER VISIT PER TREATMENT CYCLE CONSIDER EXTENDED TIME FOR RESEARCH TELECONFERENCES CRFs MONITOR VISITS

11 ESTIMATING HOURS FOR STUDY COORDINATION STUDY INITIATION > ARCHIVING STUDY INITIATION PROCESSES: ON-SITE VISIT, INSERVICE OF STAFF, AREAs SCREENING/RECRUITMENT PATIENT CARE: ENROLLMENT, PATIENT EDUCATION, TREATMENT, FOLLOW UP, TOXICITY REPORTING, QOL, DIARIES ADMINISTRATIVE: IRB, FDA, SPECIAL AREAS, MONITORS TELEPHONE, FAX, COMPUTER TIME REQUIRED HOSPITAL ROUNDS, STUDY VISITS CRF COMPLETION, QUERY RESOLUTION BILLING COMPLIANCE

12 ESTIMATING HOURS FOR DATA MANAGEMENT STUDY INITIATION > ARCHIVING STUDY INITIATION PROCESSES PATIENT CARE DOCUMENTATION: ENROLLMENT, PATIENT EDUCATION, TREATMENT, FOLLOW UP, TOXICITY REPORTING, QOL, DIARIES ADMINISTRATIVE: IRB, FDA, SPECIAL AREAS, MONITORS TELEPHONE, FAX, COPIER, COMPUTER TIME REQUIRED RADIOGRAPHIC REVIEWS RADIOLOGY, CARDIOLOGY, ETC. CRF COMPLETION, QUERY RESOLUTION STUDY ARCHIVAL

13 PHARMACY COSTS BRING in RESEARCH PHARMACIST: REVIEW and DISCUSSION of PROTOCOL DRUG ACCOUNTABILITY and STORAGE DRUG PREPARATION: MIXING, LABELING DRUG DISPENSING (INCLUDING PATIENT ED.) DELIVERY to HOSPITAL or CLINIC KNOWLEDGE of DRUG TOXICITIES/INTERACTIONS DRUG ORDERING, TRACKING EXPIRATION DATES DRUG RETURNS or DESTRUCTION at END of STUDY ADMINISTRATIVE: IRB, FDA, MONITORS, STAFF

14 LABORATORY AND PROCEDURE COSTS IDENTIFY LOCAL POLICIES and GUIDELINES --- LOCAL REVIEW --- LABS, PROCEDURES billed by Providers COSTS are TIME-SENSITIVE --- BUDGET for INCREASES ANCILLARY AREAS --- CONTACT DIRECTLY --- SPECIAL FEES --- RESEARCH ONLY SERVICES

15 PATIENT STIPENDS DETERMINED BY PROTOCOL REQUIREMENTS INVASIVE PROCEDURES TIME CONSUMING PROCEDURES EXTRA OFFICE VISITS TRAVEL TIME, PARKING PHARMACEUTICAL COMPANY or IRB INPUT

16 MISCELLANEOUS COSTS INDIRECT COSTS LOCAL IRB, CENTRAL IRB, SPECIAL RESEARCH AREAS SCREENING and RECRUITMENT, ADVERTISEMENT STORAGE (DRUG, SAMPLES, DATA) MEDICAL RECORDS MACHINE USE (COPIER, FAX, COMPUTERS, FREEZERS) SOCIAL SERVICES SUPPLIES (OFFICE, MEDICAL) ELECTRONIC DATA CAPTURE SHIPMENTS (OVERNIGHT COURIERS)

17 REMINDERS MAKE SURE THE PROTOCOL IS FINAL DATE THE BUDGET; LINK TO PROTOCOL VERSION and DATE MARK BUDGET VERSIONS ALLOW FOR ANNUAL INCREMENTAL INCREASES ENSURE SCREEN FAILURES ADDRESSED CANCELLATION FEES STUDY MONITOR VISITS/ON-CALL PAY INTERNAL START-UP MEETINGS PROTOCOL AMENDMENTS; IF COSTS, CONTACT SPONSOR to NEGOTIATE AMENDED CONTRACT BUDGET POST STUDY (QUERIES, NOTIFYING PATIENTS, FDA, ETC.)

18 ASK THE SPONSOR WILL A CENTRAL LAB BE USED? --- WILL SAMPLING SUPPLIES, SHIPPING/HANDLING MATERIALS, PRE-PAID AIRBILL BE PROVIDED? WILL THERE BE ANY OTHER CENTRAL REVIEWS? --- RADIOLOGY, NUCLEAR MEDICINE, CARDIOLOGY, ETC.? REQUEST APPLICABLE STUDY MANUALS TIMING OF MONITORING VISITS, STUDY PAYMENTS STUDY PAYMENTS VIA INVOICE --- CONSIDER AN INVOICE or ADMINISTRATIVE FEE DIRECT PAYMENT TO IRBs

19 BUDGET PREPARATION METHOD ELECTRONIC SYSTEM EXCEL SPREADSHEET WORD PROCESSOR *OBSOLETE PEN/PAPER *OBSOLETE TYPES SUMMARIZED DETAILED EXAMPLE FOLLOWS

20

21

22 REVIEW THE BUDGET WITH P.I. AND KEY PERSONNEL (CLINICAL and FINANCIAL) P.I./COORD DESIGNATES ITEMS THAT ARE STANDARD CARE (BILLED TO & REIMBURSED by THIRD PARTY PAYORS) WHEN IN DOUBT ABOUT THIRD PARTY BILLING, CHECK WITH LOCAL AREAS - COMPLIANCE OFFICE, PATIENT BILLING OFFICES, ETC.

23 FINALIZE THE BUDGET REVIEW ANY CHANGES WITH STAFF (PI, KEY PERSONNEL) REQUEST A NON-REFUNDABLE ADMINISTRATIVE START-UP FEE Separate from per patient budget or IRB fees OBTAIN APPROPRIATE INTERNAL APPROVALS SUBMIT TO SPONSOR FOR APPROVAL NEGOTIATE, NEGOTIATE, NEGOTIATE DATE BUDGET AND MARK WHEN FINAL

24 NON-REFUNDABLE ADMINSTRATIVE START-UP FEE CONSIDER THE FOLLOWING IN FEE ESTIMATION: CONFIDENTIALITY AGREEMENT PROCESS SPONSOR FEASIBILITY / SITE QUALIFICATION ATTENDANCE AT INVESTIGATOR MEETING INTERNAL REVIEWS INITIAL IRB SUBMISSION ACTIVITIES REGULATORY DOCUMENT MANAGEMENT COMPILATION, SUBMISSION TO SPONSOR, SET-UP FILES BUDGET DEVELOPMENT / NEGOTIATION INITIATION / START-UP MEETINGS

25 PAYMENT SCHEDULE NEGOTIATE ACCORDING TO THE FLOW OF THE PROTOCOL AND ESTIMATED FINANCIAL NEEDS % PER ENROLLED PATIENT % PER COMPLETED TREATMENT CYCLE % PER COMPLETED PATIENT (CHECK DEFINITION IN THE PROTOCOL and/or CONTRACT) AMOUNT PER CRF / VISIT ON A MONTHLY OR QUARTERLY BASIS

26 BUDGET MANAGEMENT SET UP STUDY ACCOUNT NUMBER IF THERE ARE MULTIPLE SOURCES OF SUPPORT FOR ONE STUDY, CONSIDER SEPARATE ACCOUNTS FOR EACH SOURCE OF SUPPORT STUDY EXPENSES CHARGED TO THE ACCOUNT NUMBER(S)

27 REIMBURSEMENT KNOW WHAT THE CLINICAL TRIAL CONTRACT SAYS TRACK/DOCUMENT: PATIENT SCREENING, PATIENT VISITS, MONITORING / CRF COLLECTION PER PATIENT PRO-ACTIVELY INVOICE THE SPONSOR UTILIZING DATA FROM ELECTRONIC MANAGEMENT SYSTEM SPREADSHEET DOCUMENTATION SPONSOR FORM OBTAIN SPONSOR APPROVAL FOR ONE-TIME or UNEXPECTED COSTS AND INVOICE AS THEY OCCUR DOCUMENT WHEN IT IS THE FINAL INVOICE

28 POST-STUDY BUDGET EVALUATION WAS THERE A BALANCE IN LABOR VS. REIMBURSEMENT? WHAT HIDDEN COSTS WERE COVERED or NOT COVERED? WERE MONITORING VISITS TOO LABOR INTENSIVE? WAS THE PAYMENT SCHEDULE EQUITABLE? IS THERE ROOM FOR IMPROVEMENT REGARDING COST OF DOING THE TRIAL AND THE BOTTOM LINE? IF YOU HAD TO DO IT OVER AGAIN, COULD YOU DO IT FOR THE SAME AMOUNT (AND NOT REQUIRE SUPPLEMENTAL RESOURCES TO COVER YOUR COSTS?)

29 BILLING COMPLIANCE REMINDER: IF THE SPONSOR IS PAYING FOR A SERVICE, DON T BILL THIRD PARTY PAYORS!

Making the Most of your Budget: Hidden Costs and Payment Terms

Making the Most of your Budget: Hidden Costs and Payment Terms Making the Most of your Budget: Hidden Costs and Payment Terms Presented by Amanda Miller and Alex Opitz 2016 PharmaSeek Financial Services, LLC d.b.a. PFS Clinical, all rights reserved Presentation Overview

More information

Evaluation of a Protocol Budget

Evaluation of a Protocol Budget Evaluation of a Budget Margaret Matula, R.N., M.G.A. Director Research & Clinical Trials Anne Arundel Medical Center Annapolis, MD IPPCR 12/15/09 Slide # 1 Introduction Determine requirements: resources

More information

Objectives es To understand: Where the money comes from to pay the coordinator s salary Where the money comes from to pay for study procedures

Objectives es To understand: Where the money comes from to pay the coordinator s salary Where the money comes from to pay for study procedures Study Budget Development 2011 Putting a budget together.where do you start? t? Presented by Phyllis Klein, RN, CCRC, BSN Director, Regulatory, Compliance & Support Center for Clinical Studies Washington

More information

PREP Workshop #29 Building Clinical Trial Budgets. Presenter: Sumathy Sundarababu Ph.D Clinical Research Service

PREP Workshop #29 Building Clinical Trial Budgets. Presenter: Sumathy Sundarababu Ph.D Clinical Research Service PREP Workshop #29 Building Clinical Trial Budgets Presenter: Sumathy Sundarababu Ph.D Clinical Research Service CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards

More information

Standard Operating Procedures. NETT Financial Plan

Standard Operating Procedures. NETT Financial Plan NETT Financial Plan Policy Overview: This policy describes the financial operations, considerations, and restrictions of the NETT. Policies and procedures outlined within include an overview of NETT funding

More information

Basics of Developing Study Budgets in Clinical Research

Basics of Developing Study Budgets in Clinical Research Basics of Developing Study Budgets in Clinical Research Office of Research Administration (ORA) Tatyana Vikhlyantseva, BS, CPCO, CCS-P, CPC Sr. Manager, Pre-Award Services Learning Objectives Recognize

More information

Presented by: Clinical Agreements Management Office of Sponsored Projects. Revised 12/04/17 PRN: 11/6/ :33 AM

Presented by: Clinical Agreements Management Office of Sponsored Projects. Revised 12/04/17 PRN: 11/6/ :33 AM Presented by: Clinical Agreements Management Office of Sponsored Projects Revised 12/04/17 PRN: 11/6/2018 10:33 AM Clinical Agreements Team: Contact Information Jeffrey Allen Director Jeffrey.Allen@yale.edu

More information

Version Date 8/22/2013 UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE

Version Date 8/22/2013 UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE UNIVERSITY OF ROCHESTER CLINICAL RESEARCH STANDARD OPERATING PROCEDURES REGARDING FINANCIAL OVERSIGHT AND BILLING COMPLIANCE I. PURPOSE The purpose of these standard operating procedures is to outline

More information

Tutorial Guide For ARIA Clinical Research Information Management System On LiNe

Tutorial Guide For ARIA Clinical Research Information Management System On LiNe Tutorial Guide For ARIA Clinical Research Information Management System On LiNe LESSON 1 ARIA Web Site Pages 3-5 LESSON 2 Log-In Process Pages 6-8 LESSON 3 Profile Update Pages 9-11 LESSON 4 ARIA Saved

More information

Office of Clinical Research

Office of Clinical Research Office of Clinical Research Kimberlea Hauser, MBA Director Catherine Jahrsdorfer, RN, BSN Director of Clinical Services July 7/8, 2011 Today s Topics USF electronic Internal Form Clinical Research Contracts

More information

Sponsorship Economics and Practicalities of Clinical Trials Budgeting and Building a Budget

Sponsorship Economics and Practicalities of Clinical Trials Budgeting and Building a Budget Sponsorship Economics and Practicalities of Clinical Trials Budgeting and Building a Budget Udo Hoffmann, MD MPH Professor of Radiology, Harvard Medical School, Chief Cardiovascular Imaging, Department

More information

CLINICAL TRIAL AGREEMENT

CLINICAL TRIAL AGREEMENT PROTOCOL TITLE: PRODUCT: INSTITUTION: PRINCIPAL INVESTIGATOR: University of Connecticut Health Center CLINICAL TRIAL AGREEMENT THIS CLINICAL TRIAL AGREEMENT together with all Exhibits and Attachments,

More information

Financing Clinical Trials Appropriate Compensa.on and Alloca.on of Study Budgets

Financing Clinical Trials Appropriate Compensa.on and Alloca.on of Study Budgets Financing Clinical Trials Appropriate Compensa.on and Alloca.on of Study Budgets Audio Op)ons Host Built- in audio on your computer OR Separate audio dial- in: 914-614- 3429, Toll- Free: 866-952- 8437,

More information

WHAT EVERY NEW PRACTITIONER SHOULD CONSIDER

WHAT EVERY NEW PRACTITIONER SHOULD CONSIDER WHAT EVERY NEW PRACTITIONER SHOULD CONSIDER January 24, 2017 Andrew N. Meyercord Gray Reed & McGraw 1601 Elm Street Suite 4600 Dallas, Texas 75201 214.954.4135 ameyercord@grayreed.com 129 attorneys Full-service,

More information

PRESCRIPTION MONITORING PROGRAM MODEL ACT

PRESCRIPTION MONITORING PROGRAM MODEL ACT Alliance of States with Prescription Monitoring Programs and National Association of State Controlled Substances Authorities Background information on the PRESCRIPTION MONITORING PROGRAM MODEL ACT October

More information

Capítulo 6 Managerial Accounting and Cost Concepts

Capítulo 6 Managerial Accounting and Cost Concepts Capítulo 6 Managerial Accounting and Concepts Exercise 1-1 (15 minutes) Object Direct 1. The wages of pediatric nurses The pediatric department 2. Prescription drugs A particular patient 3. Heating the

More information

Robert Howey, MBA, MHA, CPA Manager, Medicare Strategy Unit

Robert Howey, MBA, MHA, CPA Manager, Medicare Strategy Unit Operational Management of Medicare Organ Acquisition Cost Centers The Prac;ce of Transplant Administra;on September 12, 2016 Robert Howey, MBA, MHA, CPA Manager, Medicare Strategy Unit 2016 MFMER slide-1

More information

ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP

ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Hungarian Company representative Office ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO

More information

Investigator Site Landscape. Christine Pierre President x110

Investigator Site Landscape. Christine Pierre President x110 Investigator Site Landscape Christine Pierre President 410-696-5080 x110 Christine.pierre@myscrs.org SCRS Mission Unify the voice of the global clinical research site community for greater site sustainability.

More information

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: Date of birth: Sex: M F

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: Date of birth: Sex: M F TM RENFLEXIS for injection (inf liximab-abda)100 mg The Merck Access Program ENROLLMENT FORM Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning

More information

Application date : 07/07/2014 Procedure for submitting a new clinical research project. Véronique Baudewyns

Application date : 07/07/2014 Procedure for submitting a new clinical research project. Véronique Baudewyns Page 1 / 10 Author Service de la Recherche Biomédicale Reviewer(s) Véronique Baudewyns Approved by Jean-Michel Hougardy Public All Investigators Study Nurse Study coordinator Paramedics Admin Staff Document

More information

By Ricky Newton, CPA Director/Consultant Peninsula Cancer Institute T/A Cancer Specialists of Tidewater (757)

By Ricky Newton, CPA Director/Consultant Peninsula Cancer Institute T/A Cancer Specialists of Tidewater (757) By Ricky Newton, CPA Director/Consultant Peninsula Cancer Institute T/A Cancer Specialists of Tidewater (757) 639-4855 Rnewton@tidewatercancer.com What all physicians need to know about Hospital/Physician

More information

PREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems. Office of Research Compliance. February 16 th, 2016

PREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems. Office of Research Compliance. February 16 th, 2016 PREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems Office of Research Compliance February 16 th, 2016 1 CME Disclosure Statement The Northwell Health adheres to the ACCME

More information

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM The Merck Access Program 2019 ENROLLMENT FORM Phone: 855-257-3932, Fax: 855-755-0518 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM AND FAX IT TO

More information

Differences Between Industry-Sponsored, Industry-Supported and PI- Initiated Studies

Differences Between Industry-Sponsored, Industry-Supported and PI- Initiated Studies Differences Between Industry-Sponsored, Industry-Supported and PI- Initiated Studies Frederick M. Frankhauser, JD, MBA, RPh Director, Grants and Contracts Tufts Medical Center Different Types of Agreements

More information

Investigator Initiated Studies (IIS) Program Information Needed for Your Application

Investigator Initiated Studies (IIS) Program Information Needed for Your Application Dear Applicant: Thank you for your interest in Eisai s Investigator Initiated Studies (IIS) program. To assist you with preparing your IIS application, we have prepared a list of information that you should

More information

Patient Information. Financial Handbook For Liver Transplant Patients

Patient Information. Financial Handbook For Liver Transplant Patients Patient Information Financial Handbook For Liver Transplant Patients Beaumont Transplant Clinic Directory Beaumont Hospital, Royal Oak Medical Office Building 3535 West 13 Mile Road, Suite 644 Royal Oak,

More information

COMMERCIAL RESEARCH POLICY

COMMERCIAL RESEARCH POLICY COMMERCIAL RESEARCH POLICY Document No R&I P01 Specific staff groups to whom this policy directly applies R&I department; Clinical researchers; Finance department Likely frequency of use Monthly Other

More information

2019 Transition Policy

2019 Transition Policy 2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members

More information

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are: I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician

More information

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: _Date of birth: Sex: M F

PLEASE CHECK ALL BOXES THAT APPLY AND COMPLETE THE APPROPRIATE SECTION(S) OF THE FORM. Patient name: _Date of birth: Sex: M F The Merck Access Program ENROLLMENT FORM Phone: 855-257-3932, Fax: 855-755-0518, TTY: 855-257-7332 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM

More information

HEALTH CARE IN THE U.S.

HEALTH CARE IN THE U.S. HEALTH CARE IN THE U.S. Health Care in America! The U.S. government does not pay any part of the medical expenses for international students studying here.! The average cost of a visit to an urgent care

More information

Facilities and Administrative Cost

Facilities and Administrative Cost Georgia Regents University Policy Library Facilities and Administrative Cost Policy Owner: Sponsored Program Administration POLICY STATEMENT This policy establishes the principles for the appropriate allowable

More information

Cost Reporting 101: Your Medicare Cost Report from A - M

Cost Reporting 101: Your Medicare Cost Report from A - M Cost Reporting 101: Your Medicare Cost Report from A - M Paul Traczek, CPA, Partner Holly Pokrandt, CPA, Partner September 27, 2018 Cost Reporting 101: A Crash Course in the Basics What will be covered

More information

Contents General Information General Information

Contents General Information General Information Contents General Information... 1 Preferred Drug List... 2 Pharmacies... 3 Prescriptions... 4 Generic and Preferred Drugs... 5 Express Scripts Website and Mobile App... 5 Specialty Medicines... 5 Prior

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Payment Example 2

Payment Example 2 Clinical Trial Agreements - A Moderated Discussion Health Care Compliance Association Research Compliance Conference June 3, 2015 EXAMPLES FOR DISCUSSION 1. PERSONNEL EXAMPLES Personnel Example 1 Institution

More information

Chapter 8 Section 9.1

Chapter 8 Section 9.1 Other Services Chapter 8 Section 9.1 Issue Date: August 2002 Authority: 32 CFR 199.2(b), 32 CFR 199.4(b)(2)(vi), (b)(3)(iii), (b)(5)(v), (d)(3)(vi), (e)(11)(i), 32 CFR 199.5(d)(12); 32 CFR 199.17, and

More information

CLINICAL STUDY AGREEMENT

CLINICAL STUDY AGREEMENT CLINICAL STUDY AGREEMENT This CLINICAL STUDY AGREEMENT ( Agreement ) is made effective as of the [number] day of [month], [year] (the Effective Date ), and is by and among Recitals (1) ASTRAZENECA [PHARMACEUTICALS]

More information

Clinical Studies in H2020 Proposals

Clinical Studies in H2020 Proposals Clinical Studies in H2020 Proposals V 4.0 - March 2015 Mark Goldammer Mila Bas Sanchez Cornelius Schmaltz Directorate Health Research & Innovation European Commission Financial and Contractual Aspects

More information

Celgene Patient Support Learn about financial help for IDHIFA

Celgene Patient Support Learn about financial help for IDHIFA Celgene Patient Support Learn about financial help for IDHIFA A Celgene Patient Support Specialist can help you and your loved ones understand the programs and services available to you. CELGENE PATIENT

More information

Calculating Accurate Metrics for the Actuarial Cost Model. Introduction. William Bednar, FSA, FCA, MAAA

Calculating Accurate Metrics for the Actuarial Cost Model. Introduction. William Bednar, FSA, FCA, MAAA Calculating Accurate Metrics for the Actuarial Cost Model William Bednar, FSA, FCA, MAAA Introduction Calculating metrics for an actuarial model sounds simple enough (just sum up the data!), but if proper

More information

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic) SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Senator NIA H. GILL District (Essex and Passaic) SYNOPSIS Regulates pharmacy benefits management companies. CURRENT

More information

Tip Sheet 25: Provisions in Contracts and Funding Agreements

Tip Sheet 25: Provisions in Contracts and Funding Agreements Tip Sheet 25: Provisions in Contracts and Funding Agreements Related Accreditation Standard: I-8, Elements I.8.A., I.8.B., I.8.C., I.8.D., and I.8.E. AAHRPP Standard I-8 deals with five provisions for

More information

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP 2/14 Contents 1 Introduction... 3 2 Purpose... 3 3 Terminology and Definitions...

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

DISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY

DISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY DISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY 1. ASTELLAS S COMMITMENT 1.1 Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations ( EFPIA ). The

More information

Participant Compensation

Participant Compensation Lauren Hoctor, ORCRA/IRB, CCHMC Melinda Muenich, Clinical Trials Office, CCHMC, UC Health Participant Compensation Ethics, Taxes, and Common Practices Theoretical Models Free Market Wage Payment Reimbursement

More information

Participant s Guide to t azur Group Medical Plan

Participant s Guide to t azur Group Medical Plan Participant s Guide to t azur Group Medical Plan Introduction t azur Company b.s.c. (c), in partnership with your employer is providing you with a comprehensive healthcare plan, and we welcome you as

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Pamela Richtmyer MGH Research Compliance

Pamela Richtmyer MGH Research Compliance Pamela Richtmyer MGH Research Compliance 1 ICH E6 Financial References Remuneration and Reimbursement Research Billing Best Practices 2 ICH Guideline for Good Clinical Practice: Consolidated Guidance (E6)

More information

Impacts: CLINICAL RESEARCH Last Revised: 02/10/2012 Subject: CLINICAL STUDY BUDGET FACILITATION & INITIATION POLICY

Impacts: CLINICAL RESEARCH Last Revised: 02/10/2012 Subject: CLINICAL STUDY BUDGET FACILITATION & INITIATION POLICY POLICY AND PROCEDURE MANUAL Pennington Biomedical POLICY NO. 301.00 Origin Date: 12/01/2008 Impacts: CLINICAL RESEARCH Last Revised: 02/10/2012 Subject: CLINICAL STUDY BUDGET FACILITATION & INITIATION

More information

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP 2/14 Contents 1 Introduction... 3 2 Purpose... 3 3 Terminology and Definitions...

More information

Building Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements

Building Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements Building Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements Kelly Willenberg, DBA, RN, CHRC, CHC, CCRP Kelly Willenberg & Associates Wendy S. Portier, MSN,

More information

DOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2017 New Methodological Note

DOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2017 New Methodological Note Document Title Methodological Note EFPIA Disclosure of Transfers of Value to Healthcare Professionals and Organisations ( Methodological Note on Disclosure ) Document Version 01 Effective Date 30JUN2017

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Budgeting a Clinical Trial

Budgeting a Clinical Trial Budgeting a Clinical Trial ROBIN J. DE PAGTER O P E R A T I O N S M A N A G E R O F F I C E O F S P O N S O R E D P R O J E C T S A D M I N I S T R A T I O N M A Y O C L I N I C d e p a g t e r. r o b

More information

NeedyMeds

NeedyMeds NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.

More information

Chapter 8 Section 9.1

Chapter 8 Section 9.1 Other Services Chapter 8 Section 9.1 Issue Date: August 2002 Authority: 32 CFR 199.2(b), 32 CFR 199.4(b)(2)(vi), (b)(3)(iii), (b)(5)(v), (d)(3)(vi), (e)(11)(i), 32 CFR 199.5(d)(12); 32 CFR 199.17, and

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Health Plans Dashboard

Health Plans Dashboard Health Plans Dashboard Q2 2015 Dashboard Summary Report A review of Inpatient, Outpatient and RX trends January 14, 2016 Prepared by HSS and Aon Hewitt Introduction This report completes the first phase

More information

COLUMBIA UNIVERSITY MEDICAL CENTER INSTITUTIONAL REVIEW BOARD (IRB)

COLUMBIA UNIVERSITY MEDICAL CENTER INSTITUTIONAL REVIEW BOARD (IRB) COLUMBIA UNIVERSITY MEDICAL CENTER INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES TO COMPLY WITH PRIVACY LAWS THAT AFFECT USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION FOR RESEARCH PURPOSES Procedures

More information

IRB MOU Procedures April 2018

IRB MOU Procedures April 2018 Procedures to Implement the Reliance Memorandum of Understanding Among the University of California Campuses, UC Division of Agriculture and Natural Resources, and Lawrence Berkeley National Laboratory

More information

Medicaid Prescribed Drug Program. Spending Control Initiatives

Medicaid Prescribed Drug Program. Spending Control Initiatives Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, December 31, Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations and Spending

More information

EFPIA Transparency / LIF public reporting of transfers of value. Sobi Methodology Note Transfers of Value (reported 2017) Sweden

EFPIA Transparency / LIF public reporting of transfers of value. Sobi Methodology Note Transfers of Value (reported 2017) Sweden EFPIA Transparency / LIF public reporting of transfers of value Sobi Methodology Note 2016 Transfers of Value (reported 2017) Sweden 1 1. Background A new disclosure code was approved by European Federation

More information

Template for essential information to be provided for proposals including clinical trials / studies / investigations. Version 1.

Template for essential information to be provided for proposals including clinical trials / studies / investigations. Version 1. Template for essential information to be provided for proposals including clinical trials / studies / investigations Version 1.1 1 February 2015 IMI2/INT/2015-00354 History of changes Version Date Change

More information

Cost Reporting Principles April 4, 2007

Cost Reporting Principles April 4, 2007 Reimbursement Primer for Compliance, Ethics and Legal Officers: Everything You Have Always Wanted to Know About Reimbursement but Were Afraid to Ask. Cost Reporting Principles April 4, 2007 Douglas J.

More information

Healthcare. insurance. Helping people live healthier lives

Healthcare. insurance. Helping people live healthier lives Healthcare insurance Helping people live healthier lives You Deserve the Best Care Life uncertainties are inevitable. Your employees and their dependents are bound to face health issues at some time or

More information

(AMA Council on Ethical and Judicial Affairs, Code of Medical Ethics, 7.05 Retention of Medical Records, ed.)

(AMA Council on Ethical and Judicial Affairs, Code of Medical Ethics, 7.05 Retention of Medical Records, ed.) RECORD RETENTION AND DESTRUCTION FOR WYOMING ENTITIES By Kim C. Stanger, Melissa Y. Lou, and Chris D. Mack (rev d 8/21/18) Record. Ideally, healthcare providers should retain medical and other business

More information

Aetna. CCHCA Physician Handbook (7 th Edition)

Aetna. CCHCA Physician Handbook (7 th Edition) Part II Section A Aetna Introduction 1 Verifying Aetna Member Eligibility and Benefits 1 Aetna Sample Member ID Card 2 Aetna Prescription Drug Program 3 Pharmacy Benefit 4 Prior Authorization for Medications

More information

Physician Office Solutions

Physician Office Solutions Physician Office Solutions In the ever-changing world of healthcare, you can rely on us to help you improve your practice to face the challenges to come. Commitment That Extends Far Beyond Products We

More information

DOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2016 New Methodological Note

DOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2016 New Methodological Note Document Title Methodological Note EFPIA Disclosure of Transfers of Value to Healthcare Professionals and Organisations in Poland ( Methodological Note on Disclosure ) Document Version 01 Effective Date

More information

Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office

Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP

More information

Get a 1-month supply of ENTRESTO at no cost to you *

Get a 1-month supply of ENTRESTO at no cost to you * Get a 1-month supply of ENTRESTO at no cost to you * FREE TRIAL OFFER * For all patients A program designed to guide you through treatment *Limitations apply. This voucher is good for a 30-day (maximum

More information

*This document is searchable.

*This document is searchable. CCHP Prior Authorization List and Toll Free Phone Number 877-227-1142 Fax Number 414-266-4726 www. Childrenschp.com(childrenscommunityhealthplan.org) Utilization Provider Portal: provider.childrenscommunityhealthplan.org

More information

Frequently Asked Questions (FAQs) About the LIPITOR Savings Program*

Frequently Asked Questions (FAQs) About the LIPITOR Savings Program* Frequently Asked Questions (FAQs) About the LIPITOR Savings Program* *Terms and conditions apply. Please see page 9 for details. You may pay less by receiving the generic. Below are some FAQs about the

More information

Medicare Transition POLICY AND PROCEDURES

Medicare Transition POLICY AND PROCEDURES Medicare Transition POLICY AND PROCEDURES POLICY The Plan will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug Benefit Manual

More information

SAN FRANCISCO INTERNATIONAL AIRPORT SFO MEDICAL CLINIC RFP CONTRACT NO PRE-PROPOSAL CONFERENCE AUGUST 23, 2017

SAN FRANCISCO INTERNATIONAL AIRPORT SFO MEDICAL CLINIC RFP CONTRACT NO PRE-PROPOSAL CONFERENCE AUGUST 23, 2017 SAN FRANCISCO INTERNATIONAL AIRPORT SFO MEDICAL CLINIC RFP CONTRACT NO. 50118.01 PRE-PROPOSAL CONFERENCE AUGUST 23, 2017 1 AGENDA Introduction (Gerardo Fries B&F) Sign-Up Sheet / Participants Names & Organizations

More information

C o s t R e p o r t i n g : M e d i c a r e C o s t R e p o r t M o r e t h a n j u s t C o m p l i a n c e J u l y 1 8,

C o s t R e p o r t i n g : M e d i c a r e C o s t R e p o r t M o r e t h a n j u s t C o m p l i a n c e J u l y 1 8, Cost Reporting 201: M edicare Cost Report More than just Compliance July 18, 2016 Wipfli LLP Wipfli LLP Agenda What will be covered today: Uses of information included in the Medicare Cost Report for a

More information

Inside: Critical information about your company s prescription drug benefit.

Inside: Critical information about your company s prescription drug benefit. Inside: Critical information about your company s prescription drug benefit. Questions Company Benefits Managers Must Ask Their PBM It pays to make an informed decision harmacy Benefit Managers, often

More information

Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code

Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Date Published: 31 May 2017 Index Annex 1: The disclosure in accordance with the Schedule 2 Template Annex

More information

For Yale Faculty, Staff, and Students only

For Yale Faculty, Staff, and Students only For Yale Faculty, Staff, and Students only Budget Book Fiscal Year 2017 Cover photo: Brandon Boyer YC 15 Analyst, Office of Financial Planning & Analysis, Yale University FY17 Operating and Capital Budget

More information

The Merck Access Program ENROLLMENT FORM

The Merck Access Program ENROLLMENT FORM The Merck Access Program ENROLLMENT FORM P: 877-709-4455 F: 800-977-1957 The Merck Access Program, PO Box 29067, Phoenix, AZ 85038 TO GET STARTED, COMPLETE THE ENROLLMENT FORM AND FAX IT TO 800-977-1957.

More information

Pay as little as a $10 co-pay a month for ENTRESTO *

Pay as little as a $10 co-pay a month for ENTRESTO * Pay as little as a $10 co-pay a month for ENTRESTO * $10 CO-PAY CARD * For eligible commercially insured patients A program designed to guide you through treatment *Limitations apply. This offer is not

More information

Clinical Research Organisation Model Clinical Trial Agreement (CRO-mCTA)

Clinical Research Organisation Model Clinical Trial Agreement (CRO-mCTA) Model Clinical Trial Agreement (mcta) and Clinical Research Organisation Model Clinical Trial Agreement (CRO-mCTA) Guidance February 2018 Model Clinical Trial Agreement and Clinical Research Organisation

More information

NeedyMeds

NeedyMeds NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.

More information

2019 Transition Policy and Procedure

2019 Transition Policy and Procedure 2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process

More information

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3 Date Published: 15 th March 2017 Version: 20 (December 4, 2015) Index Methodology for Compliance with the ABPI Disclosure Code Introduction Page 1 General Comments Page 2 Indirect Transfers of Value Page

More information

Pharmaceutical Management Commercial Plans

Pharmaceutical Management Commercial Plans Pharmaceutical Management Commercial Plans 2015 Toll Free Contact Number: (888) 327-0671 Medical Management: (810) 733-9711 Visit our website at: MclarenHealthPlan.org Introduction Pharmaceutical Management

More information

HEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE

HEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE HEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE Model development was made possible by the generous support of the American people through the United States Agency for International Development (USAID).

More information

All Indiana Health Coverage Programs Physicians, Podiatrists, Dentists, Hospitals, Clinics, Mental Health Providers, and Pharmacies

All Indiana Health Coverage Programs Physicians, Podiatrists, Dentists, Hospitals, Clinics, Mental Health Providers, and Pharmacies Indiana Health Coverage Programs P R O V I D E R B U L L E T I N BT200132 AUGUST 10, 2001 To: All Indiana Health Coverage Programs Physicians, Podiatrists, Dentists, Hospitals, Clinics, Mental Health Providers,

More information

Inspiration Health by HealthEast MN % City of Minneapolis Coverage Period: Beginning on or after 1/1/2017 Summary of Benefits and Coverage:

Inspiration Health by HealthEast MN % City of Minneapolis Coverage Period: Beginning on or after 1/1/2017 Summary of Benefits and Coverage: This is only a summary: If you want more detail about your coverage and costs, you can get the complete terms in the policy or plan document at www.medica.com or by calling 1-855-469-6334. Important Questions

More information

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification. 1 INSURANCE SECTION : This section contains information about the cardholder and their plan identification. 1 ID of Cardholder Required. Enter the recipient s 13 digit Medicaid ID. 2 Group ID Not Required.

More information

Prescription Drug Coverage

Prescription Drug Coverage The Company s medical plans automatically include coverage for prescription drugs which is administered by Envision Pharmaceutical Services, Inc. (Envision Rx) for prescriptions filled at retail pharmacies

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca UK Limited Registered in England No 3674842 Registered Office, 2 Kingdom Street, London,

More information

Glossary of Terms. Adjudication: The way a health plan decides how much it will pay for certain expenses.

Glossary of Terms. Adjudication: The way a health plan decides how much it will pay for certain expenses. Page 1 Glossary of Terms Adjudication: The way a health plan decides how much it will pay for certain expenses. Affordable Care Act (ACA): The comprehensive health care reform law enacted in March 2010.

More information

PROVIDER MANUAL. In the Colorado Access Provider Manual, you will find information about:

PROVIDER MANUAL. In the Colorado Access Provider Manual, you will find information about: In the Colorado Access Provider Manual, you will find information about: Section 1. Colorado Access General Information Section 2. Colorado Access Policies Section 3. Quality Management Section 4. Provider

More information

The Health Plan has processes in place that explain how members, pharmacists, and physicians:

The Health Plan has processes in place that explain how members, pharmacists, and physicians: Introduction Overview The Health Plan shall promote optimal therapeutic use of pharmaceuticals by encouraging the use of cost effective generic and/or brand drugs in certain therapeutic classes. The Health

More information

Guide to Identifying and Measuring Private Business Use in Tax-Exempt Bond-Financed Facilities

Guide to Identifying and Measuring Private Business Use in Tax-Exempt Bond-Financed Facilities Guide to Identifying and Measuring Private Business Use in Tax-Exempt Bond-Financed Facilities I. Introduction The University of Washington (the University ) frequently finances facilities in whole or

More information

Any healthcare professional and healthcare organization whose primary practice, principal professional address or place of incorporation

Any healthcare professional and healthcare organization whose primary practice, principal professional address or place of incorporation METHODOLOGICAL NOTE on the EFPIA disclosure of transfers of value to healthcare professionals and organizations Country: Russia Last Update: 25.04.2018 Version: 02; this document replaces previous drafts

More information